galcanezumab-gnlm
Study Shows Anti-CGRP Monoclonal Antibody Agents as Future Treatment for Neuropathic Pain
A study has used a novel approach to treat neuropathic pain effectively with monoclonal antibodies that block ...
SEPTEMBER 15, 2021
FDA Approves First Treatment for Episodic Cluster Headache
People with episodic cluster headache represent 85% to 90% of cluster headache prevalence, with approximately ...
JUNE 5, 2019
Load more